The Cytotoxic Necrotizing Factor of Yersinia pseudotuberculosis (CNFY) Enhances Inflammation and Yop Delivery during Infection by Activation of Rho GTPases

PLoS Pathogens

Volumn 9, Issue 11, 2013, Pages

  Schweer, Janina ^a   Kulkarni, Devesha ^a   Kochut, Annika ^a   Pezoldt, Joern ^a   Pisano, Fabio ^a   Pils, Marina C ^a   Genth, Harald ^b   Huehn, Jochen ^a   Dersch, Petra ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC NECROTIZING FACTOR 1; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; YERSINIA OUTER PROTEIN E;

ACTIN FILAMENT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL VIRULENCE; COLONY FORMING UNIT; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE SEVERITY; FEMALE; HISTOLOGY; HOST PATHOGEN INTERACTION; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SURVIVAL RATE; YERSINIA PSEUDOTUBERCULOSIS INFECTION;

ANIMALS; BACTERIAL TOXINS; CDC42 GTP-BINDING PROTEIN; ENZYME ACTIVATION; HUMANS; MICE; MICE, INBRED BALB C; NEUROPEPTIDES; PROTEIN TRANSPORT; RAC1 GTP-BINDING PROTEIN; RHO GTP-BINDING PROTEINS; YERSINIA PSEUDOTUBERCULOSIS; YERSINIA PSEUDOTUBERCULOSIS INFECTIONS;

EID: 84888227426     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1003746     Document Type: Article

References (95)

1. Carniel E, Autenrieth A, Cornelis G, Fukushima H, Guinet F (2002) Y. enterocolitica and Y. pseudotuberculosis. In: Dworkin M, Falkow S, Rosenberg E, Scheifer KH, Stackebrandt E, editors. The Prokaryotes: An evolving electronic resource for the microbiological community. New York: Springer.
2. Viboud GI, Bliska JB, (2005) Yersinia outer proteins: role in modulation of host cell signaling responses and pathogenesis. Annu Rev Microbiol 59: 69-89.
3. Cornelis GR, Boland A, Boyd AP, Geuijen C, Iriarte M, et al. (1998) The virulence plasmid of Yersinia, an antihost genome. Microbiol Mol Biol Rev 62: 1315-1352.
4. Cornelis GR, (2006) The type III secretion injectisome. Nat Rev Microbiol 4: 811-825.
5. Kudryashev M, Stenta M, Schmelz S, Amstutz M, Wiesand U, et al. (2013) In situ structural analysis of the Yersinia enterocolitica injectisome. eLIFE 2: e00792.
6. Bliska JB, (2000) Yop effectors of Yersinia spp. and actin rearrangements. Trends Microbiol 8: 205-208.
7. Black DS, Bliska JB, (1997) Identification of p130Cas as a substrate of Yersinia YopH (Yop51), a bacterial protein tyrosine phosphatase that translocates into mammalian cells and targets focal adhesions. Embo J 16: 2730-2744.
8. Bliska JB, Guan KL, Dixon JE, Falkow S, (1991) Tyrosine phosphate hydrolysis of host proteins by an essential Yersinia virulence determinant. Proc Natl Acad Sci U S A 88: 1187-1191.
9. Persson C, Carballeira N, Wolf-Watz H, Fallman M, (1997) The PTPase YopH inhibits uptake of Yersinia, tyrosine phosphorylation of p130Cas and FAK, and the associated accumulation of these proteins in peripheral focal adhesions. EMBO J 16: 2307-2318.
10. Guan KL, Dixon JE, (1990) Protein tyrosine phosphatase activity of an essential virulence determinant in Yersinia. Science 249: 553-556.
11. Wong KW, Isberg RR, (2005) Yersinia pseudotuberculosis spatially controls activation and misregulation of host cell Rac1. PLoS Pathog 1: e16.
12. Lemaitre N, Sebbane F, Long D, Hinnebusch BJ, (2006) Yersinia pestis YopJ suppresses tumor necrosis factor alpha induction and contributes to apoptosis of immune cells in the lymph node but is not required for virulence in a rat model of bubonic plague. Infect Immun 74: 5126-5131.
13. Monack DM, Mecsas J, Ghori N, Falkow S, (1997) Yersinia signals macrophages to undergo apoptosis and YopJ is necessary for this cell death. Proc Natl Acad Sci U S A 94: 10385-10390.
14. Mukherjee S, Keitany G, Li Y, Wang Y, Ball HL, et al. (2006) Yersinia YopJ acetylates and inhibits kinase activation by blocking phosphorylation. Science 312: 1211-1214.
15. Zheng Y, Lilo S, Brodsky IE, Zhang Y, Medzhitov R, et al. (2011) A Yersinia effector with enhanced inhibitory activity on the NF-kappaB pathway activates the NLRP3/ASC/caspase-1 inflammasome in macrophages. PLoS Pathog 7: e1002026.
16. Zhang Y, Bliska JB, (2010) YopJ-promoted cytotoxicity and systemic colonization are associated with high levels of murine interleukin-18, gamma interferon, and neutrophils in a live vaccine model of Yersinia pseudotuberculosis infection. Infect Immun 78: 2329-2341.
17. Skrzypek E, Cowan C, Straley SC, (1998) Targeting of the Yersinia pestis YopM protein into HeLa cells and intracellular trafficking to the nucleus. Mol Microbiol 30: 1051-1065.
18. Hentschke M, Berneking L, Belmar Campos C, Buck F, Ruckdeschel K, et al. (2010) Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation. PLoS One 5: e13165.
19. McDonald C, Vacratsis PO, Bliska JB, Dixon JE, (2003) The Yersinia virulence factor YopM forms a novel protein complex with two cellular kinases. J Biol Chem 278: 18514-18523.
20. Ye Z, Kerschen EJ, Cohen DA, Kaplan AM, van Rooijen N, et al. (2009) Gr1+ cells control growth of YopM-negative Yersinia pestis during systemic plague. Infect Immun 77: 3791-3806.
21. Kerschen EJ, Cohen DA, Kaplan AM, Straley SC, (2004) The plague virulence protein YopM targets the innate immune response by causing a global depletion of NK cells. Infect Immun 72: 4589-4602.
22. Thorslund SE, Ermert D, Fahlgren A, Erttmann SF, Nilsson K, et al. (2012) Role of YopK in Yersinia pseudotuberculosis resistance against polymorphonuclear leukocyte defense. Infect Immun 81: 11-22.
23. Thorslund SE, Edgren T, Pettersson J, Nordfelth R, Sellin ME, et al. (2011) The RACK1 signaling scaffold protein selectively interacts with Yersinia pseudotuberculosis virulence function. PLoS One 6: e16784.
24. Dewoody R, Merritt PM, Houppert AS, Marketon MM, (2011) YopK regulates the Yersinia pestis type III secretion system from within host cells. Mol Microbiol 79: 1445-1461.
25. Viboud GI, Bliska JB, (2001) A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J 20: 5373-5382.
26. Mejia E, Bliska JB, Viboud GI, (2008) Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog 4: e3.
27. Lockman HA, Gillespie RA, Baker BD, Shakhnovich E, (2002) Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect Immun 70: 2708-2714.
28. Hoffmann C, Pop M, Leemhuis J, Schirmer J, Aktories K, et al. (2004) The Yersinia pseudotuberculosis cytotoxic necrotizing factor (CNFY) selectively activates RhoA. J Biol Chem 279: 16026-16032.
29. Lemonnier M, Landraud L, Lemichez E, (2007) Rho GTPase-activating bacterial toxins: from bacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol Rev 31: 515-534.
30. Knust Z, Schmidt G, (2010) Cytotoxic Necrotizing Factors (CNFs)-A Growing Toxin Family. Toxins (Basel) 2: 116-127.
31. Caprioli A, Falbo V, Roda LG, Ruggeri FM, Zona C, (1983) Partial purification and characterization of an Escherichia coli toxic factor that induces morphological cell alterations. Infect Immun 39: 1300-1306.
32. Blanco J, Gonzalez EA, Garcia S, Blanco M, Regueiro B, et al. (1988) Production of toxins by Escherichia coli strains isolated from calves with diarrhoea in galicia (north-western Spain). Vet Microbiol 18: 297-311.
33. Kouokam JC, Wai SN, Fallman M, Dobrindt U, Hacker J, et al. (2006) Active cytotoxic necrotizing factor 1 associated with outer membrane vesicles from uropathogenic Escherichia coli. Infect Immun 74: 2022-2030.
34. Davis JM, Carvalho HM, Rasmussen SB, O'Brien AD, (2006) Cytotoxic necrotizing factor type 1 delivered by outer membrane vesicles of uropathogenic Escherichia coli attenuates polymorphonuclear leukocyte antimicrobial activity and chemotaxis. Infect Immun 74: 4401-4408.
35. Buetow L, Flatau G, Chiu K, Boquet P, Ghosh P, (2001) Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat Struct Biol 8: 584-588.
36. Lemichez E, Flatau G, Bruzzone M, Boquet P, Gauthier M, (1997) Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol Microbiol 24: 1061-1070.
37. Contamin S, Galmiche A, Doye A, Flatau G, Benmerah A, et al. (2000) The p21 Rho-activating toxin cytotoxic necrotizing factor 1 is endocytosed by a clathrin-independent mechanism and enters the cytosol by an acidic-dependent membrane translocation step. Mol Biol Cell 11: 1775-1787.
38. Blumenthal B, Hoffmann C, Aktories K, Backert S, Schmidt G, (2007) The cytotoxic necrotizing factors from Yersinia pseudotuberculosis and from Escherichia coli bind to different cellular receptors but take the same route to the cytosol. Infect Immun 75: 3344-3353.
39. Knust Z, Blumenthal B, Aktories K, Schmidt G, (2009) Cleavage of Escherichia coli cytotoxic necrotizing factor 1 is required for full biologic activity. Infect Immun 77: 1835-1841.
40. Gerhard R, Schmidt G, Hofmann F, Aktories K, (1998) Activation of Rho GTPases by Escherichia coli cytotoxic necrotizing factor 1 increases intestinal permeability in Caco-2 cells. Infect Immun 66: 5125-5131.
41. Schmidt G, Sehr P, Wilm M, Selzer J, Mann M, et al. (1997) Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature 387: 725-729.
42. Lerm M, Selzer J, Hoffmeyer A, Rapp UR, Aktories K, et al. (1999) Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1: activation of c-Jun N-terminal kinase in HeLa cells. Infect Immun 67: 496-503.
43. Schmidt G, Selzer J, Lerm M, Aktories K, (1998) The Rho-deamidating cytotoxic necrotizing factor 1 from Escherichia coli possesses transglutaminase activity. Cysteine 866 and histidine 881 are essential for enzyme activity. J Biol Chem 273: 13669-13674.
44. Flatau G, Lemichez E, Gauthier M, Chardin P, Paris S, et al. (1997) Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature 387: 729-733.
45. May M, Kolbe T, Wang T, Schmidt G, Genth H, (2012) Increased cell-matrix adhesion upon constitutive activation of Rho proteins by cytotoxic necrotizing factors from E. coli and Y. pseudotuberculosis. J Signal Transduct 2012: 570183.
46. Huelsenbeck SC, May M, Schmidt G, Genth H, (2009) Inhibition of cytokinesis by Clostridium difficile toxin B and cytotoxic necrotizing factors-reinforcing the critical role of RhoA in cytokinesis. Cell Motil Cytoskeleton 66: 967-975.
47. Falzano L, Fiorentini C, Donelli G, Michel E, Kocks C, et al. (1993) Induction of phagocytic behaviour in human epithelial cells by Escherichia coli cytotoxic necrotizing factor type 1. Mol Microbiol 9: 1247-1254.
48. Hofman P, Le Negrate G, Mograbi B, Hofman V, Brest P, et al. (2000) Escherichia coli cytotoxic necrotizing factor-1 (CNF-1) increases the adherence to epithelia and the oxidative burst of human polymorphonuclear leukocytes but decreases bacteria phagocytosis. J Leukoc Biol 68: 522-528.
49. Visvikis O, Boyer L, Torrino S, Doye A, Lemonnier M, et al. (2011) Escherichia coli producing CNF1 toxin hijacks Tollip to trigger Rac1-dependent cell invasion. Traffic 12: 579-590.
50. Hopkins AM, Walsh SV, Verkade P, Boquet P, Nusrat A, (2003) Constitutive activation of Rho proteins by CNF-1 influences tight junction structure and epithelial barrier function. J Cell Sci 116: 725-742.
51. Hofman P, Flatau G, Selva E, Gauthier M, Le Negrate G, et al. (1998) Escherichia coli cytotoxic necrotizing factor 1 effaces microvilli and decreases transmigration of polymorphonuclear leukocytes in intestinal T84 epithelial cell monolayers. Infect Immun 66: 2494-2500.
52. Mills M, Meysick KC, O'Brien AD, (2000) Cytotoxic necrotizing factor type 1 of uropathogenic Escherichia coli kills cultured human uroepithelial 5637 cells by an apoptotic mechanism. Infect Immun 68: 5869-5880.
53. Grabenstein JP, Marceau M, Pujol C, Simonet M, Bliska JB, (2004) The response regulator PhoP of Yersinia pseudotuberculosis is important for replication in macrophages and for virulence. Infect Immun 72: 4973-4984.
54. Böhme K, Steinmann R, Kortmann J, Seekircher S, Heroven AK, et al. (2012) Concerted actions of a thermo-labile regulator and a unique intergenic RNA thermosensor control Yersinia virulence. PLoS Pathog 8: e1002518.
55. Logsdon LK, Mecsas J, (2003) Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun 71: 4595-4607.
56. Harmon DE, Davis AJ, Castillo C, Mecsas J, (2010) Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob Agents Chemother 54: 3241-3254.
57. Gao W, Xing B, Tsien RY, Rao J, (2003) Novel fluorogenic substrates for imaging beta-lactamase gene expression. J Am Chem Soc 125: 11146-11147.
58. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, et al. (1998) Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279: 84-88.
59. Durand EA, Maldonado-Arocho FJ, Castillo C, Walsh RL, Mecsas J, (2010) The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell Microbiol 12: 1064-1082.
60. Huelsenbeck J, Dreger S, Gerhard R, Barth H, Just I, et al. (2007) Difference in the cytotoxic effects of toxin B from Clostridium difficile strain VPI 10463 and toxin B from variant Clostridium difficile strain 1470. Infect Immun 75: 801-809.
61. Just I, Huelsenbeck SC, Genth H, (2010) Clostridium botulinum C3 exoenzyme: Rho-inactivating tool in cell biology and a neurotrophic agent. The Open Toxicology Journal 3: 19-23.
62. Black DS, Bliska JB, (2000) The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence. Mol Microbiol 37: 515-527.
63. Aili M, Isaksson EL, Hallberg B, Wolf-Watz H, Rosqvist R, (2006) Functional analysis of the YopE GTPase-activating protein (GAP) activity of Yersinia pseudotuberculosis. Cell Microbiol 8: 1020-1033.
64. Aili M, Hallberg B, Wolf-Watz H, Rosqvist R, (2002) GAP activity of Yersinia YopE. Methods Enzymol 358: 359-370.
65. Songsungthong W, Higgins MC, Rolan HG, Murphy JL, Mecsas J, (2010) ROS-inhibitory activity of YopE is required for full virulence of Yersinia in mice. Cell Microbiol 12: 988-1001.
66. Bergsbaken T, Cookson BT, (2007) Macrophage activation redirects Yersinia-infected host cell death from apoptosis to caspase-1-dependent pyroptosis. PLoS Pathog 3: e161.
67. Etienne-Manneville S, Hall A, (2002) Rho GTPases in cell biology. Nature 420: 629-635.
68. Rippere-Lampe KE, Lang M, Ceri H, Olson M, Lockman HA, et al. (2001) Cytotoxic necrotizing factor type 1-positive Escherichia coli causes increased inflammation and tissue damage to the prostate in a rat prostatitis model. Infect Immun 69: 6515-6519.
69. Rippere-Lampe KE, O'Brien AD, Conran R, Lockman HA, (2001) Mutation of the gene encoding cytotoxic necrotizing factor type 1 (cnf(1)) attenuates the virulence of uropathogenic Escherichia coli. Infect Immun 69: 3954-3964.
70. Bergsbaken T, Cookson BT, (2009) Innate immune response during Yersinia infection: critical modulation of cell death mechanisms through phagocyte activation. J Leukoc Biol 86: 1153-1158.
71. Philip NH, Brodsky IE, (2012) Cell death programs in Yersinia immunity and pathogenesis. Front Cell Infect Microbiol 2: 149.
72. Fink SL, Cookson BT, (2005) Apoptosis, pyroptosis, and necrosis: mechanistic description of dead and dying eukaryotic cells. Infect Immun 73: 1907-1916.
73. Savill J, Dransfield I, Gregory C, Haslett C, (2002) A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2: 965-975.
74. Brodsky IE, Palm NW, Sadanand S, Ryndak MB, Sutterwala FS, et al. (2010) A Yersinia effector protein promotes virulence by preventing inflammasome recognition of the type III secretion system. Cell Host Microbe 7: 376-387.
75. Monack DM, Mecsas J, Bouley D, Falkow S, (1998) Yersinia-induced apoptosis in vivo aids in the establishment of a systemic infection of mice. J Exp Med 188: 2127-2137.
76. Meinzer U, Barreau F, Esmiol-Welterlin S, Jung C, Villard C, et al. (2012) Yersinia pseudotuberculosis effector YopJ subverts the Nod2/RICK/TAK1 pathway and activates caspase-1 to induce intestinal barrier dysfunction. Cell Host Microbe 11: 337-351.
77. Wolters M, Boyle EC, Lardong K, Truelzsch K, Steffen A, et al. (2013) Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac. J Biol Chem 288 (32):: 23543-53.
78. Aili M, Isaksson EL, Carlsson SE, Wolf-Watz H, Rosqvist R, et al. (2008) Regulation of Yersinia Yop-effector delivery by translocated YopE. Int J Med Microbiol 298: 183-192.
79. Keestra AM, Winter MG, Auburger JJ, Frassle SP, Xavier MN, et al. (2013) Manipulation of small Rho GTPases is a pathogen-induced process detected by NOD1. Nature 496: 233-237.
80. Boyer L, Travaglione S, Falzano L, Gauthier NC, Popoff MR, et al. (2004) Rac GTPase instructs nuclear factor-kappaB activation by conveying the SCF complex and IkBalpha to the ruffling membranes. Mol Biol Cell 15: 1124-1133.
81. Sambrook J (2001) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratories,.
82. Miller JH (1992) A short course in bacterial genetic: a laboratory manual and handbook for Escherichia coli and related bacteria. Cold Spring Habor, New York: Laboratories CSH.
83. Nagel G, Lahrz A, Dersch P, (2001) Environmental control of invasin expression in Yersinia pseudotuberculosis is mediated by regulation of RovA, a transcriptional activator of the SlyA/Hor family. Mol Microbiol 41: 1249-1269.
84. Heroven AK, Dersch P, (2006) RovM, a novel LysR-type regulator of the virulence activator gene rovA, controls cell invasion, virulence and motility of Yersinia pseudotuberculosis. Mol Microbiol 62: 1469-1483.
85. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O, (2005) Plague bacteria target immune cells during infection. Science 309: 1739-1741.
86. Studier FW, Moffatt BA, (1986) Use of bacteriophage T7 RNA polymerase to direct selective high-level expression. J Mol Biol 189: 113-130.
87. Manoil C, Beckwith J, (1986) A genetic approach to analyzing membrane protein topology. Science 233: 1403-1408.
88. Simon R, Priefer U, Puehler A, (1983) A broad host range mobilization system for in vivo genetic engineering: transposon mutagenesis in gram negative bacteria. Biotechnology 1: 784-791.
89. Bolin I, Forsberg A, Norlander L, Skurnik M, Wolf-Watz H, (1988) Identification and mapping of the temperature-inducible, plasmid-encoded proteins of spp. Infect Immun 56: 343-348.
90. Chain PS, Carniel E, Larimer FW, Lamerdin J, Stoutland PO, et al. (2004) Insights into the evolution of Yersinia pestis through whole-genome comparison with Yersinia pseudotuberculosis. Proc Natl Acad Sci U S A 101: 13826-13831.
91. Chang AC, Cohen SN, (1978) Construction and characterization of amplifiable multicopy DNA cloning vehicles derived from the P15A cryptic miniplasmid. J Bacteriol 134: 1141-1156.
92. Milton DL, O'Toole R, Horstedt P, Wolf-Watz H, (1996) Flagellin A is essential for the virulence of Vibrio anguillarum. J Bacteriol 178: 1310-1319.
93. Uliczka F, Pisano F, Kochut A, Opitz W, Herbst K, et al. (2011) Monitoring of gene expression in bacteria during infections using an adaptable set of bioluminescent, fluorescent and colorigenic fusion vectors. PLoS One 6: e20425.
94. Pisano F, Kochut A, Uliczka F, Geyer R, Stolz T, et al. (2012) In vivo-induced InvA-like autotransporters Ifp and InvC of Yersinia pseudotuberculosis promote interactions with intestinal epithelial cells and contribute to virulence. Infect Immun 80: 1050-1064.
95. Derbise A, Lesic B, Dacheux D, Ghigo JM, Carniel E, (2003) A rapid and simple method for inactivating chromosomal genes in Yersinia. FEMS Immunol Med Microbiol 38: 113-116.